Based on recently published findings of Zabel and co-workers, who demonstrated that CXCR4/CXCR7 co-expressing lymphoblastic tumor cells exhibited significantly enhanced trans-endothelial migration compared to cells expressing CXCR4 alone [13,31]. The gene discussed is CXCR4; the disease is neoplasm.